Blood cancer arises from abnormal blood cell production in the bone marrow, disrupting normal function. Early detection through regular check-ups is c ...

Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and ...

Zhuo, C., et al. (2025). Single-cell sequencing reveals the expansion and diversity of T cell subsets in the bone marrow ...

Researchers at University of Tsukuba have identified multiple T-cell subtypes with unique characteristics in follicular ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...

Cero will use Invivoscribe's multiparametric flow cytometry assay to detect minimal residual disease in patients and evaluate the therapy's efficacy.

Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, ...

Several ASX-listed biotechs are advancing cell therapies to capture a share of a global market projected to reach US$48 ...

Planned C-section births may increase the risk of childhood leukemia, particularly B-cell acute lymphoblastic leukemia, with ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Mayo Clinic physician and researcher Dr. Abba Zubair's work combines two passions—medicine and space—for the benefit of astronauts and people on Earth. His research in space is yielding discoveries in ...

T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive form of blood cancer that can occur in both children and ...